Please use this identifier to cite or link to this item:
|Title:||Current practices of Asia-Pacific cardiologists in the utilization of bioresorbable scaffolds.|
|Epworth Authors:||Dick, Ronald|
|Other Authors:||Chanana, Bharat Bhushan|
Huan, Do Quang
Soo, Chee Siong
Yap, Yee Guan
Absorb Bioresorbable Vascular Scaffolds
Blood Vessel Prosthesis
Statistics & Numerical Data
Coronary Artery Disease
Cardiac Sciences Clinical Institute, Epworth HealthCare, Victoria, Australia
|Citation:||Int J Cardiol. 2016 Nov 1;222:832-40|
|Abstract:||BACKGROUND & AIMS: Although Absorb Bioresorbable Vascular Scaffolds (A-BVS) are routinely used in the Asia-Pacific, there is little information on patient selection or deployment technique here. This document investigates the experiences of leading interventional cardiologists from the Asia-Pacific region with a focus on patient characteristics, deployment techniques and management. METHODS AND RESULTS: A detailed questionnaire was distributed to 28 highly-experienced interventional cardiologists ('Authors') from 13 Asia-Pacific countries. The results were discussed at a meeting on patient selection, technical consideration, deployment practices and patient management. Potential patient benefits of Absorb compared to metallic DES, the learning curve for patient selection and preparation, device deployment, and subsequent patient management approaches are presented. CONCLUSIONS: Current practices are derived from guidelines optimized for European patients. Differences in approach exist in the Asia-Pacific context, including limited access to imaging and frequency of occurrence of complex lesions. Nevertheless, the use of the Absorb BVS ('Absorb') in certain Asia-Pacific countries has flourished and practices here are continuing to mature.|
|Journal Title:||International Journal of Cardiology|
|Affiliated Organisations:||Maharaja Agrasen Hospital, New Delhi, India.|
Medanta Medicity, Haryana, India.
Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan.
Samsung Medical Center, Seoul, Republic of Korea.
Ruby Hall Clinic, Pune, Maharashtra, India.
Heart Institute HCM, Ho Chi Minh City, Vietnam.
Police General Hospital, Bangkok, Thailand.
The Second Hospital of Tianjin Medical University, Tianjin, China.
Hong Kong Sanatorium & Hospital, Hongkong, China.
Mount Elizabeth Novena Hospital, Singapore, Singapore.
National University Hospital, Singapore, Singapore.
Lisie Hospital, Ernakulam, Kerala, India.
Lilavati Hospital, Mumbai, India.
Christchurch Hospital, Christchurch, New Zealand.
New Tokyo Hospital, Chiba, Japan.
Fiona Stanley Hospital, Murdoch, Australia.
Fuwai Cardiovascular Hospital, Beijing, China.
Medistra Hospital, Jakarta, Indonesia.
Max Hospital, New Delhi, India.
Royal Perth Hospital Campus, University of Western Australia, Australia.
Apollo Hospital, Chennai, India.
Fortis Escorts Heart Institute, India.
Abbott Vascular, Santa Clara, USA.
HSC Medical Centre, Kuala Lumpur, Malaysia.
Mackay Memorial Hospital, Taipei, Taiwan.
King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
Prince Court Medical Centre, Kuala Lumpur, Malaysia.
|Type of Clinical Study or Trial:||Multicentre Studies|
|Appears in Collections:||Cardiac Sciences|
Files in This Item:
There are no files associated with this item.
Items in EKB are protected by copyright, with all rights reserved, unless otherwise indicated.